Could a cheap drug shield kidneys from diabetes damage?
NCT ID NCT04929379
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study tests whether fenofibrate, a drug typically used to lower blood fats, can prevent kidney function loss in people with type 1 diabetes who are at high risk of kidney failure. Forty participants will receive either fenofibrate or a placebo for 18 months, and their kidney function will be measured. The goal is to gather information for a larger trial and see if this drug can protect the kidneys.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brehm Center for Diabetes Research / University of Michigan
Ann Arbor, Michigan, 48105, United States
-
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
-
Lahey Hospital and Medical center
Burlington, Massachusetts, 01805, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13210, United States
Conditions
Explore the condition pages connected to this study.